Breast carcinoma is the most common malignant tumor and the leading cause of death from cancer in women. 1 Patients are evaluated based on history, examination, imaging, Fine needle aspiration cytology (FNAC) and then comparing with histopathology. FNAC is being performed as a pre-operative test to evaluate breast lump. FNAC is cost effective and can prevent unnecessary surgery. It has been noted in previous studies that there is a wide variation between the clinical features, FNAC and histopathology in the case of breast lumps. Author wanted to know how valid this variation is among population group and assess the sensitivity and specificity of FNAC. on 30 patients.
Statistical analysis
The statistical analysis was performed using SPSS 18.0. The categorical variables was analysed using frequencies and percentages.
RESULTS
The mean age group of woman in the study was 28.4 years.70% were of the age group 21-40 years. 10% aged 41-60 years and 10% were than 20 years of age. About 5% were >60 years of age ( Figure 1 ).
Figure 1: Mean age group in the study.
On clinical examination 64% (19) of the patients were thought to have benign breast lumps and 36% (11) were thought to have malignant lesions.
As per FNAC, 64 % were reported as fibroadenoma, 30% of the patients were reported as suggestive of malignancy and 6% as suspicious of malignancy (Table 1) . Histopathology showed that 60% of the patients had fibroadenoma, 33% were found to carcinoma breast and 7% had benign phyllodes tumor (Table 2) . 
DISCUSSION
FNAC of breast is commonly used as part of the diagnostic triad, which in addition includes clinical breast examination and radiological examination. (mammography and ultrasonography). 2 Excision biopsy remains "gold standard" with 100% sensitivity. 3 However compared to FNAC, excision biopsy is expensive and associated with greater degree of patient morbidity. 4 Open biopsy leaves a visible scar that is cosmetically undesirable and has a significantly longer turnaround time. 5, 6 However for FNAC both false negative and false positive results can occur. The sensitivity of FNAC ranges from 80%-98% and the specificity maybe up to 100% as per previous studies. 5 In this study, definitive diagnosis was available in 96% of cases. A similar study done by Hirachand et al, found that 5.6% were benign disease of breast, 64.2% cases as fibroadenoma, 7.5% were suggestive of malignancy,2 2.7% suspicious of malignancy on FNAC and 89.6% turned out to be fibroadenoma, 3.6% fibrocystic disease, 3.8% had duct ectesia and 1.9% was phyllodes on histopathology. 7 Kiran et al, did a study which showed that 21.3% were benign lesions, 56.7% cases were fibroadenoma, 14.7% suggestive of malignancy and 7.3% suspicious of malignancy on FNAC while 74% had fibroadenoma, 19.3% had invasive ductal carcinoma, 2.7% had Vishnu VK et al. Int Surg J. 2019 Nov; 6(11):4095-4097 International Surgery Journal | November 2019 | Vol 6 | Issue 11 Page 4097 phyllodes tumor, 2.7% showed pagets disease on histopathology. 8 From this study with a mean age group of patients ranging from 21-40 years, 64% were fibroadenoma, 30% reported as suggestive of malignancy and 6% as suspicious of malignancy on FNAC. On histopathology, 60% of the patients had fibroadenoma, 33% were found to have carcinoma and 7% had benign phyllodes tumor. 4% of the cases which were thought to be benign turned out to be malignant on histopathology. FNAC was found to have a sensitivity of 96.6% and a specificity of.
CONCLUSION
FNAC is a reliable, fast and accurate diagnostic method for the assessment of breast lumps. It has manageable complications and can be performed on an outpatient basis, thereby reducing hospital stay. Due to its early turnover time FNAC could be employed as an early diagnostic tool.
